What is he best known for?
The fields of study he is best known for:
- Biochemistry
- Internal medicine
- Enzyme
The scientist’s investigation covers issues in Fasciola hepatica, Liver fluke, Triclabendazole, Pathology and Trematoda.
He works on Fasciola hepatica which deals in particular with Hepatica.
His Liver fluke research incorporates elements of Fasciola and Drug resistance.
His studies deal with areas such as Veterinary medicine and Pharmacology, Drug as well as Triclabendazole.
In his work, Syncytium, Stimulation and Cytoplasm is strongly intertwined with Viral tegument, which is a subfield of Pathology.
The various areas that Ian Fairweather examines in his Trematoda study include Peripheral nervous system, Central nervous system and Anatomy.
His most cited work include:
- Drug resistance in veterinary helminths (643 citations)
- Fasciolicides: Efficacy, Actions, Resistance and its Management (201 citations)
- Understanding triclabendazole resistance. (183 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Fasciola hepatica, Liver fluke, Triclabendazole, Pathology and Molecular biology.
His studies in Fasciola hepatica integrate themes in fields like Ultrastructure, Trematoda, Viral tegument and Andrology.
As a member of one scientific family, Ian Fairweather mostly works in the field of Liver fluke, focusing on Biochemistry and, on occasion, Ouabain.
He combines subjects such as Veterinary medicine, Anthelmintic, Pharmacology and Drug resistance with his study of Triclabendazole.
Ian Fairweather has included themes like In vitro, Syncytium and In vivo in his Pathology study.
His Molecular biology study incorporates themes from Tubulin, Immunocytochemistry and Pancreatic polypeptide.
He most often published in these fields:
- Fasciola hepatica (48.75%)
- Liver fluke (29.89%)
- Triclabendazole (26.33%)
What were the highlights of his more recent work (between 2008-2020)?
- Fasciola hepatica (48.75%)
- Triclabendazole (26.33%)
- Liver fluke (29.89%)
In recent papers he was focusing on the following fields of study:
Ian Fairweather spends much of his time researching Fasciola hepatica, Triclabendazole, Liver fluke, Pathology and Hepatica.
His Fasciola hepatica study is related to the wider topic of Immunology.
His Triclabendazole research integrates issues from Drug metabolism, Ovary, Drug resistance, Pharmacology and Histology.
His Liver fluke study which covers Incubation that intersects with Efflux.
His Pathology research is multidisciplinary, relying on both Trematoda, Helminths, Viral tegument and Vacuole.
His biological study spans a wide range of topics, including Antibody, Fasciolosis and Physiology.
Between 2008 and 2020, his most popular works were:
- Triclabendazole progress report, 2005-2009: an advancement of learning? (132 citations)
- Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy? (106 citations)
- Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep (67 citations)
In his most recent research, the most cited papers focused on:
- Biochemistry
- Internal medicine
- Enzyme
His primary areas of investigation include Fasciola hepatica, Triclabendazole, Liver fluke, Veterinary medicine and Hepatica.
His Fasciola hepatica research is multidisciplinary, incorporating elements of Ovary and Pathology.
Ian Fairweather interconnects Trematoda, Andrology, Viral tegument and In vivo in the investigation of issues within Pathology.
His research integrates issues of Drug, Pharmacology, Drug metabolism, Molecular biology and Drug resistance in his study of Triclabendazole.
His Veterinary medicine study combines topics from a wide range of disciplines, such as Climate effects, Food safety and Fasciola.
His Hepatica study combines topics in areas such as Feces, Oxfendazole and Albendazole.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
